Uridine Diphosphate Glucuronosyltransferase 2B7 Variant p.His268Tyr as a Predictor of Kidney Allograft Early Acute Rejection

IDENTIFICATION OF THE UDP-GLUCURONOSYLTRANSFERASE ISOFORMS INVOLVED IN MYCOPHENOLIC ACID PHASE II METABOLISM

Nicolas Picard, Damrong Ratanasavanh, Aurélie Prémaud et al. · Drug Metabolism and Disposition · 2004 · 276 citations

Life Sciences, Biochemistry, Pharmacology +15

The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers

Éric Lévesque, Robert Delage, Patrick Caron et al. · Clinical Pharmacology & Therapeutics · 2007 · 160 citations

Veterinary Medicine, Genetics, Pharmacology +17

A novel functional polymorphism in the uridine diphosphate–glucuronosyltransferase 2B7 promoter with significant impact on promoter activity

Yannick Duguay, Cecilie Báár, Frank Skorpen et al. · Clinical Pharmacology & Therapeutics · 2004 · 149 citations

Medicine, Genetics, Pharmacology +15

Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects?

Eberhard Wieland, Maria Shipkova, Ulrike Schellhaas et al. · Clinical Biochemistry · 2000 · 143 citations

Life Sciences, Immunology, Pharmacology +14

UGT1A9 -275T>A/-2152C>T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus-Treated Kidney Transplant Patients

Ron H. N. van Schaik, Madelon van Agteren, Johan W. de Fijter et al. · Clinical Pharmacology & Therapeutics · 2009 · 120 citations

Medicine, Pharmacokinetics, Pharmacology +17